Silent Theatre presentations
Programme stream(s): Silent theatre
Programme session type(s): No session type
Date and time: Sun 04-Nov-2018, 18/01/2019 19:40-18/01/2019 21:00
Room: Silent theatre 2 - Hall 4
These theatres provide an area for accepted abstract submitters to present their research in 5 minute presentations.
The abstract presentations in this session are:
19.40 – Natalie Cook, Carcinoma of unknown primary: Diagnosis, treatment and outcomes in a tertiary cancer centre
19.46 – Lyn Jones, Comparison of performance of mammogram readers with breast MRI readers at an abbreviated breast MRI interpretation task: Results from a single centre multireader study using an enhanced data-set
19.52 – Mohanarangam Thangavelu, Role of staging bone scans in the patients with newly diagnosed prostate cancer. Are the current guidelines acceptable?
19.58 – Daniel Ball, T-stage migration by routine pre-biopsy MRI staging may affect risk assessment with current risk classification systems
20.04 – Hester Franks, Adenosine polarises human macrophages towards an immunosuppressive phenotype via the A2A and A2B adenosine receptors
20.10 – Qiuyu Wang, Anticancer activity of arabinoxylan on human gastric adenocarcinoma cells in vitro
20.16 – Robin Grant, Seizure Prophylaxis in Glioma (SPRING): A phase III randomised trial comparing prophylactic Levetiracetam versus no prophylactic anti-epileptic drug in newly diagnosed presumed supratentorial glioma.
20.22 – Kate Butcher, Development of nano-enabled disulfiram reverses pan-chemoresistance by inhibiting hypoxia induced cancer stem cells in non-small cell lung cancer
20.28 – Helen Ross-Adams, PIXdb: Exploring the transcriptomic landscape of prostate cancer development and progression
20.34 – Na Hyun Kim, Propensity Score-Matched Comparison of Focal High Intensity Focused Ultrasound (HIFU) to Laparoscopic Radical Prostatectomy (LRP) for Clinically Significant Localised Prostate Cancer
20.40 – Peter Coussons, Differential redistribution of transglutaminase isoforms in cisplatin resistant hepatocarcinoma (HEPG2) cells
20.46 – Surbhi Kaul, SMC1A: a novel candidate DNA damage biomarker in hair follicles
20.52 – Fiona Blows, Investigation of transglutaminase 2 as a biomarker of invasive breast cancer that is likely to metastasise